We are live on
!
Find out more
MCM
Masters Capital Management Portfolio holdings
AUM
$3.03B
1-Year Est. Return
57.21%
This Fund
S&P 500
This Quarter
Est. Return
+3.22%
1 Year Est. Return
+57.21%
3 Year Est. Return
+118.82%
5 Year Est. Return
+120.72%
10 Year Est. Return
+600.65%
AUM
$2.46B
AUM Growth
+$39.7M
(+1.6%)
Cap. Flow
+$36.3M
Cap. Flow
% of AUM
1.47%
Top 10 Holdings %
Top 10 Hldgs %
49.76%
Holding
81
New
13
Increased
20
Reduced
11
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$26.6M |
| 2 |
Ford
F
|
+$18.4M |
| 3 |
United Airlines
UAL
|
+$13.9M |
| 4 |
Viatris
VTRS
|
+$13.4M |
| 5 |
PRTY
Party City Holdco Inc.
PRTY
|
+$11.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$41.3M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$29.6M |
| 3 |
Alcoa
AA
|
+$25.1M |
| 4 |
NCR Voyix
VYX
|
+$14.5M |
| 5 |
Designer Brands
DBI
|
+$14.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 4.79% |
| 2 | Financials | 3.68% |
| 3 | Energy | 3% |
| 4 | Healthcare | 2.73% |
| 5 | Industrials | 2.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
CALL
Oracle
ORCL
$367B
| – | – |
-500,000
| Closed | -$43.6M |
|
77
CALL
Pfizer
PFE
$142B
| – | – |
-1,000,000
| Closed | -$43M |
|
|
78
CALL
NCR Voyix
VYX
$1.12B
| – | – |
-815,000
| Closed | -$19.4M |
|
|
X
79
CALL
DELISTED
US Steel
X
| – | – |
-1,000,000
| Closed | -$22M |
|
|
TMDI
80
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
| – | – |
-1,500,000
| Closed | -$2.28M |
|
|
MNDT
81
DELISTED
Mandiant, Inc. Common Stock
MNDT
| – | – |
-750,000
| Closed | -$13.3M |
|
Similar funds
CM
JIC
CFM
SM
TAM
MB
KIA
MCM
Masters Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Masters Capital Management held 81 positions worth $2.46B, up 1.6% from $2.42B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Masters Capital Management's Q4 2021 filing shows 13 new, 20 increased, 11 reduced and 20 closed positions. Its largest new stake was Citigroup: 400,000 shares worth $24.2M. The largest sale was Gilead Sciences, an estimated $41.3M.
By sector, the portfolio is most concentrated in Materials at 4.8% of assets, down from 5.3% a quarter earlier, followed by Financials and Energy.
- Masters Capital Management's largest Q4 2021 buy was Citigroup: 400,000 shares worth $24.2M.
- Masters Capital Management added most to Viatris in Q4 2021, an estimated $13.4M increase.
- Masters Capital Management's biggest Q4 2021 reduction was Alcoa, cutting an estimated $25.1M.
- Masters Capital Management fully exited Gilead Sciences in Q4 2021, selling an estimated $41.3M.
- Masters Capital Management's ten largest holdings make up 50% of its $2.46B portfolio in Q4 2021.
- Masters Capital Management opened 13 new positions and closed 20 in Q4 2021.
- Masters Capital Management's portfolio value rose 1.6% quarter-over-quarter to $2.46B.
Based on Masters Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.